President & CEO of Momenta Pharmaceuticals Inc (30-Year Financial, Insider Trades) Craig A Wheeler (insider trades) sold 21,104 shares of MNTA on 02/04/2020 at an average price of $30.03 a share. The total sale was $633,753.
Momenta Pharmaceuticals Inc is a biotechnology company. It is engaged in developing generic versions of complex drugs, biosimilars and novel therapeutics for oncology and autoimmune disease. Momenta Pharmaceuticals Inc has a market cap of $3.05 billion; its shares were traded at around $30.84 with and P/S ratio of 45.28. Momenta Pharmaceuticals Inc had annual average EBITDA growth of 4.50% over the past five years. GuruFocus has detected 3 severe warning signs with Momenta Pharmaceuticals Inc. .
CEO Recent Trades:
- President & CEO Craig A Wheeler sold 21,104 shares of MNTA stock on 02/04/2020 at the average price of $30.03. The price of the stock has increased by 2.7% since.
Directors and Officers Recent Trades:
- Chief HR and Inf. Officer Jo Ann Beltramello sold 1,219 shares of MNTA stock on 01/24/2020 at the average price of $28.19. The price of the stock has increased by 9.4% since.
- Chief Legal Officer Alejandra Carvajal sold 1,577 shares of MNTA stock on 01/22/2020 at the average price of $28.98. The price of the stock has increased by 6.42% since.
- Chief Mfg and Program Officer Ian Fier sold 1,577 shares of MNTA stock on 01/22/2020 at the average price of $28.98. The price of the stock has increased by 6.42% since.
- Chief Scientific Officer Anthony M. Manning sold 2,265 shares of MNTA stock on 01/22/2020 at the average price of $29.01. The price of the stock has increased by 6.31% since.
- Chief Mfg and Program Officer Ian Fier sold 860 shares of MNTA stock on 01/21/2020 at the average price of $30.08. The price of the stock has increased by 2.53% since.
For the complete insider trading history of MNTA, click here
.
